Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis
CONCLUSION: Switching to oral semaglutide ameliorated β-cell function compared with DPP-4is, presumably via tissue-to-tissue crosstalk between liver and β-cells.PMID:38695547 | DOI:10.1210/clinem/dgae213
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Hiroshi Nomoto Sho Furusawa Hiroki Yokoyama Yuka Suzuki Rimi Izumihara Yuki Oe Kiyohiko Takahashi Aika Miya Hiraku Kameda Kyu Yong Cho Jun Takeuchi Yoshio Kurihara Akinobu Nakamura Tatsuya Atsumi Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | Fortamet | Insulin | Liver | Metformin | Urology & Nephrology